Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D; pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;
elironrasib (RMC-6291),a RAS(ON) G12C-selective inhibitor;
zoldonrasib (RMC-9805),a RAS(ON) G12D-selective inhibitor;
and RMC-5127, a RAS(ON)G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity The Senior Manager, Field Market Access will be responsible to ensure and optimize access of Revolution Medicines’ pipeline at a regional level, building strategic relationships and engaging with regional payers/payer organizations (and their influencers),



and public affairs stakeholders.
This individual is a field based employee with extensive market access experience who is responsible of the development of projects, budgetary control and to present value evidences tools to payers and those with budgetary responsibility at regional level. The Senior Manager, Field Market Access’ activity is designed to shape a favourable environment for our products and services through effective and targeted communication with payers at a Regional and Local level as dictated by the local country business.
Essential Responsibilities Define and implement Market Access strategies to ensure access of Revolution Medicines products at Regional and Hospital level by demonstrating their therapeutic, economic and societal value using a deep knowledge of the Regional environment in collaboration with Senior Oncology

📌 Senior Manager, Field Market Access, Spain (Madrid)
🏢 Revolution Medicines
📍 Madrid